The optic nerve: A "mito-window" on mitochondrial neurodegeneration

Molecular and Cellular Neuroscience

Volumn 55, Issue , 2013, Pages 62-76

  Maresca, Alessandra ^a   la Morgia, Chiara ^a   Caporali, Leonardo ^a   Valentino, Maria Lucia ^a   Carelli, Valerio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

DOA; LHON; Mitochondrial disease; Mitochondrial functions; Optic atrophy; Retinal ganglion cells

Indexed keywords

MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ALZHEIMER DISEASE; APOPTOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; OPTIC NERVE; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL; REVIEW; SPASTIC PARAPLEGIA; SPINOCEREBELLAR DEGENERATION; VISUAL DISORDER;

ANIMALS; GENES, MITOCHONDRIAL; GENETIC THERAPY; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; OPTIC NERVE;

VASCONCELLEA CANDICANS;

EID: 84875578257     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.08.004     Document Type: Review

References (272)

1. Alavi M.V., Bette S., Schimpf S., Schuettauf F., Schraermeyer U., Wehrl H.F., Ruttiger L., Beck S.C., Tonagel F., Pichler B.J., Knipper M., Peters T., Laufs J., Wissinger B. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain 2007, 130:1029-1042.
2. Albano E., Bellomo G., Parola M., Dianzani M.U. Stimulation of lipid peroxidation increases the intracellular calcium content of isolated hepatocytes. Biochim. Biophys. Acta 1991, 1091:310-316.
3. Alexander C., Votruba M., Pesch U.E., Thiselton D.L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., Bhattacharya S.S., Wissinger B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000, 26:211-215.
4. Amati-Bonneau P., Valentino M.L., Reynier P., Gallardo M.E., Bornstein B., Boissiere A., Campos Y., Rivera H., de la Aleja J.G., Carroccia R., Iommarini L., Labauge P., Figarella-Branger D., Marcorelles P., Furby A., Beauvais K., Letournel F., Liguori R., La Morgia C., Montagna P., Liguori M., Zanna C., Rugolo M., Cossarizza A., Wissinger B., Verny C., Schwarzenbacher R., Martin M.A., Arenas J., Ayuso C., Garesse R., Lenaers G., Bonneau D., Carelli V. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008, 131:338-351.
5. Amiott E.A., Lott P., Soto J., Kang P.B., McCaffery J.M., DiMauro S., Abel E.D., Flanigan K.M., Lawson V.H., Shaw J.M. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations. Exp. Neurol. 2008, 211:115-127.
6. Amr S., Heisey C., Zhang M., Xia X.-J., Shows K.H., Ajlouni K., Pandya A., Satin L.S., El-Shanti H., Shiang R. A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am. J. Hum. Genet. 2007, 81:673-683.
7. Anderson P.R., Kirby K., Orr W.C., Hilliker A.J., Phillips J.P. Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:611-616.
8. Angebault C., Gueguen N., Desquiret-Dumas V., Chevrollier A., Guillet V., Verny C., Cassereau J., Ferre M., Milea D., Amati-Bonneau P., Bonneau D., Procaccio V., Reynier P., Loiseau D. Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration. BMC Res. Notes 2011, 4:557.
9. Anikster Y., Kleta R., Shaag A., Gahl W.A., Elpeleg O. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am. J. Hum. Genet. 2001, 69:1218-1224.
10. Archibald N.K., Clarke M.P., Mosimann U.P., Burn D.J. The retina in Parkinson's disease. Brain 2009, 132:1128-1145.
11. Armstrong J.S., Khdour O., Hecht S.M. Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. FASEB J. 2010, 24:2152-2163.
12. Assink J.J.M., Tijmes N.T., ten Brink J.B., Oostra R.-J., Riemslag F.C., de Jong P.T.V.M., Bergen A.A.B. A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome. Am. J. Hum. Genet. 1997, 61:934-939.
13. Babcock M., de Silva D., Oaks R., Davis-Kaplan S., Jiralerspong S., Montermini L., Pandolfo M., Kaplan J. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 1997, 276:1709-1712.
14. Ban T., Heymann J.A., Song Z., Hinshaw J.E., Chan D.C. OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. Hum. Mol. Genet. 2010, 19:2113-2122.
15. Baracca A., Solaini G., Sgarbi G., Lenaz G., Baruzzi A., Schapira A.H., Martinuzzi A., Carelli V. Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. Arch. Neurol. 2005, 62:730-736.
16. Barbet F., Hakiki S., Orssaud C., Gerber S., Perrault I., Hanein S., Ducroq D., Dufier J.L., Munnich A., Kaplan J., Rozet J.M. A third locus for dominant optic atrophy on chromosome 22q. J. Med. Genet. 2005, 42(1):e1. (Jan).
17. Barbet F., Gerber S., Hakiki S., Perrault I., Hanein S., Ducroq D., Tanguy G., Dufier J.L., Munnich A., Kaplan J., Rozet J.M. A first locus for isolated autosomal recessive optic atrophy (ROA1) maps to chromosome 8q21-q22. Adv. Exp. Med. Biol. 2006, 572:21-27.
18. Barboni P., Savini G., Valentino M.L., Montagna P., Cortelli P., De Negri A.M., Sadun F., Bianchi S., Longanesi L., Zanini M., de Vivo A., Carelli V. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005, 112:120-126.
19. Barboni P., Savini G., Valentino M.L., La Morgia C., Bellusci C., De Negri A.M., Sadun F., Carta A., Carbonelli M., Sadun A.A., Carelli V. Leber's hereditary optic neuropathy with childhood onset. Invest. Ophthalmol. Vis. Sci. 2006, 47:5303-5309.
20. Barboni P., Carbonelli M., Savini G., Foscarini B., Parisi V., Valentino M.L., Carta A., De Negri A., Sadun F., Zeviani M., Sadun A.A., Schimpf S., Wissinger B., Carelli V. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size. Ophthalmology 2010, 117:1547-1553.
21. Barboni P., Carbonelli M., Savini G., Ramos Cdo.V.F., Carta A., Berezovsky A., Salomao S.R., Carelli V., Sadun A.A. Natural history of Leber's hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology 2010, 117:623-627.
22. Barboni P., Savini G., Parisi V., Carbonelli M., La Morgia C., Maresca A., Sadun F., De Negri A.M., Carta A., Sadun A.A., Carelli V. Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age. Ophthalmology 2011, 118:2076-2080.
23. Barnils N., Mesa E., Muñoz S., Ferrer-Artola A., Arruga J. Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy. Arch. Soc. Esp. Oftalmol. 2007, 82:377-380.
24. Barrett T.G., Scott-Brown M., Seller A., Bednarz A., Poulton K., Poulton J. The mitochondrial genome in Wolfram syndrome. J. Med. Genet. 2000, 37:463-466.
25. Bayer A.U., Ferrari F., Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur. Neurol. 2002, 47:165-168.
26. Benard G., Faustin B., Passerieux E., Galinier A., Rocher C., Bellance N., Delage J.P., Casteilla L., Letellier T., Rossignol R. Physiological diversity of mitochondrial oxidative phosphorylation. Am. J. Physiol. Cell Physiol. 2006, 291:1172-1182.
27. Beretta S., Mattavelli L., Sala G., Tremolizzo L., Schapira A.H., Martinuzzi A., Carelli V., Ferrarese C. Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain 2004, 127:2183-2192.
28. Berisha F., Feke G.T., Trempe C.L., McMeel J.W., Schepens C.L. Retinal abnormalities in early Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 2007, 48:2285-2289.
29. Birch-Machin M.A., Taylor R.W., Cochran B., Ackrell B.A., Turnbull D.M. Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Ann. Neurol. 2000, 48:330-335.
30. Blakely E.L., de Silva R., King A., Schwarzer V., Harrower T., Dawidek G., Turnbull D.M., Taylor R.W. LHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation. Eur. J. Hum. Genet. 2005, 13:623-627.
31. Blanks J.C., Torigoe Y., Hinton D.R., Blanks R.H. Retinal pathology in Alzheimer's disease. Ganglion cell loss in foveal/parafoveal retina. Neurobiol. Aging 1996, 17:377-384.
32. Blanks J.C., Schmidt S.Y., Torigoe Y., Porrello K.V., Hinton D.R., Blanks R.H. Retinal pathology in Alzheimer's disease. Regional neuron loss and glial changes in GCL. Neurobiol. Aging 1996, 17:385-395.
33. Blok M.J., Spruijt L., de Coo I.F., Schoonderwoerd K., Hendrickx A., Smeets H.J. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease. J. Med. Genet. 2007, 44:e74.
34. Bodis-Wollner I. Retinopathy in Parkinson Disease. J. Neural Transm. 2009, 116:1493-1501.
35. Bodis-Wollner I., Yahr M.D. Measurements of visual evoked potentials in Parkinson's disease. Brain 1978, 101:661-671.
36. Bodis-Wollner I., Marx M.S., Mitra S., Bobak P., Mylin L., Yahr M. Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain 1987, 110:1675-1698.
37. Bohr V.A. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic. Biol. Med. 2002, 32:804-812.
38. Brandt U. Energy converting NADH:quinone oxidoreductase (complex I). Annu. Rev. Biochem. 2006, 75:69-92.
39. Bruno C., Martinuzzi A., Tang Y., Andreu A.L., Pallotti F., Bonilla E., Shanske S., Fu J., Sue C.M., Angelini C., DiMauro S., Manfredi G. A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV. Am. J. Hum. Genet. 1999, 65:611-620.
40. Bruyn G.W., Went L.N. A sex-linked heredo-degenerative neurological disorder associated with Leber's hereditary optic atrophy: Part I. clinical studies. J. Neurol. Sci. 1964, 1:59-80.
41. Bu X.D., Rotter J.I. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:8198-8202.
42. Büeler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp. Neurol. 2009, 218:235-246.
43. Bundey S., Fielder A., Poulton K. Wolfram syndrome: mitochondrial disorder. Lancet 1993, 342:1059-1060.
44. Burbulla L.F., Krebiehl G., Krüger R. Balance is the challenge - the impact of mitochondrial dynamics in Parkinson's disease. Eur. J. Clin. Invest. 2010, 40:1048-1060.
45. Campuzano V., Montermini L., Molto M.D., Pianese L., Cossee M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., Zara F., Canizares J., Koutnikova H., Bidichandani S.I., Gellera C., Brice A., Trouillas P., De Michele G., Filla A., De Frutos R., Palau F., Patel P.I., Di Donato S., Mandel J.L., Cocozza S., Koenig M., Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271:1423-1427.
46. Carelli V., Bellan M. Myelin, mitochondria, and autoimmunity: what's the connection?. Neurology 2008, 70:1075-1076.
47. Carelli V., Ghelli A., Ratta M., Bacchilega E., Sangiorgi S., Mancini R., Leuzzi V., Cortelli P., Montagna P., Lugaresi E., Degli Esposti M. Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology 1997, 48:1623-1632.
48. Carelli V., Barboni P., Zacchini A., Mancini R., Monari L., Cevoli S., Liguori R., Sensi M., Lugaresi E., Montagna P. Leber's hereditary optic neuropathy (LHON) with 14484/ND6 mutation in a North African patient. J. Neurol. Sci. 1998, 160:183-188.
49. Carelli V., Ghelli A., Bucchi L., Montagna P., De Negri A., Leuzzi V., Carducci C., Lenaz G., Lugaresi E., Degli Esposti M. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy. Ann. Neurol. 1999, 45:320-328.
50. Carelli V., Ross-Cisneros F.N., Sadun A.A. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem. Int. 2002, 40:573-584.
51. Carelli V., Giordano C., d'Amati G. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet. 2003, 19:257-262.
52. Carelli V., Ross-Cisneros F.N., Sadun A.A. Mitochondrial dysfunction as a cause of optic neuropathies. Prog. Retin. Eye Res. 2004, 23:53-89.
53. Carelli V., Achilli A., Valentino M.L., Rengo C., Semino O., Pala M., Olivieri A., Mattiazzi M., Pallotti F., Carrara F., Zeviani M., Leuzzi V., Carducci C., Valle G., Simionati B., Mendieta L., Salomao S., Belfort R., Sadun A.A., Torroni A. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am. J. Hum. Genet. 2006, 78:564-774.
54. Carelli V., La Morgia C., Iommarini L., Carroccia R., Mattiazzi M., Sangiorgi S., Farne' S., Maresca A., Foscarini B., Lanzi L., Amadori M., Bellan M., Valentino M.L. Mitochondrial optic neuropathies: how two genomes may kill the same cell type?. Biosci. Rep. 2007, 27:173-184.
55. Carelli V., La Morgia C., Valentino M.L., Barboni P., Ross-Cisneros F.N., Sadun A.A. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. Biochim. Biophys. Acta 2009, 1787:518-528.
56. Carelli V., La Morgia C., Valentino M.L., Rizzo G., Carbonelli M., De Negri A.M., Sadun F., Carta A., Guerriero S., Simonelli F., Sadun A.A., Aggarwal D., Liguori R., Avoni P., Baruzzi A., Zeviani M., Montagna P., Barboni P. Idebenone treatment in Leber's hereditary optic neuropathy. Brain 2011, 134:e188.
57. Carelli V., Schimpf S., Fuhrmann N., Valentino M.L., Zanna C., Iommarini L., Papke M., Schaich S., Tippmann S., Baumann B., Barboni P., Longanesi L., Rugolo M., Ghelli A., Alavi M.V., Youle R.J., Bucchi L., Carroccia R., Giannoccaro M.P., Tonon C., Lodi R., Cenacchi G., Montagna P., Liguori R., Wissinger B. A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16. Hum. Mol. Genet. 2011, 20:1893-1905.
58. Carroll J., Fearnley I.M., Skehel J.M., Shannon R.J., Hirst J., Walker J.E. Bovine complex I is a complex of 45 different subunits. J. Biol. Chem. 2006, 281:32724-32727.
59. Carta A., Carelli V., D'Adda T., Ross-Cisneros F.N., Sadun A.A. Human extraocular muscles in mitochondrial diseases: comparing chronic progressive external ophthalmoplegia with Leber's hereditary optic neuropathy. Br. J. Ophthalmol. 2005, 89:825-827.
60. Cartoni R., Léger B., Hock M.B., Praz M., Crettenand A., Pich S., Ziltener J.L., Luthi F., Dériaz O., Zorzano A., Gobelet C., Kralli A. Russell AP. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 2005, 567:349-358.
61. Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., De Michele G., Filla A., Cocozza S., Marconi R., Durr A., Fontaine B., Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998, 93:973-983.
62. Cavanagh J.B., Harding B.N. Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 1994, 117:1357-1376.
63. Chadderton N., Palfi A., Millington-Ward S., Gobbo O., Overlack N., Carrigan M., O'Reilly M., Campbell M., Ehrhardt C., Wolfrum U., Humphries P., Kenna P.F., Jane Farrar G. Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy. Eur. J. Hum. Genet. 2012, (Epub ahead of print). 10.1038/ejhg.2012.112.
64. Chau C.A., Evans M.J., Scarpulla R.C. Nuclear respiratory factor 1 activation sites in genes encoding the gamma-subunit of ATP synthase, eukaryotic initiation factor 2α, tyrosine aminotransferase. Specific interaction of purified NRF-1 with multiple target genes. J. Biol. Chem. 1992, 267:6999-7006.
65. Chen Y.F., Kao C.H., Chen Y.T., Wang C.H., Wu C.Y., Tsai C.Y., Liu F.C., Yang C.W., Wei Y.H., Hsu M.T., Tsai S.F., Tsai T.F. Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev. 2009, 23(10):1183-1194. (May 15).
66. Chevrollier A., Guillet V., Loiseau D., Gueguen N., de Crescenzo M.A., Verny C., Ferre M., Dollfus H., Odent S., Milea D., Goizet C., Amati-Bonneau P., Procaccio V., Bonneau D., Reynier P. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann. Neurol. 2008, 63:794-798.
67. Chinnery P.F., Howell N., Lightowlers R.N., Turnbull D.M. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 1997, 120:1713-1721.
68. Chinnery P.F., Brown D.T., Andrews R.M., Singh-Kler R., Riordan-Eva P., Lindley J., Applegarth D.A., Turnbull D.M., Howell N. The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy. Brain 2001, 124:209-218.
69. Chol M., Lebon S., Benit P., Chretien D., de Lonlay P., Goldenberg A., Odent S., Hertz-Pannier L., Vincent-Delorme C., Cormier-Daire V., Rustin P., Rotig A., Munnich A. The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J. Med. Genet. 2003, 40:188-191.
70. Cipolat S., Rudka T., Hartmann D., Costa V., Serneels L., Craessaerts K., Metzger K., Frezza C., Annaert W., D'Adamio L., Derks C., Dejaegere T., Pellegrini L., D'Hooge R., Scorrano L., De Strooper B. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 2006, 126:163-175.
71. Cohn A.C., Toomes C., Hewitt A.W., Kearns L.S., Inglehearn C.F., Craig J.E., Mackey D.A. The natural history of OPA1-related autosomal dominant optic atrophy. Br. J. Ophthalmol. 2008, 92:1333-1336.
72. Cordeiro M.F., Guo L., Coxon K.M., Duggan J., Nizari S., Normando E.M., Sensi S.L., Sillito A.M., Fitzke F.W., Salt T.E., Moss S.E. Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell. Death Dis. 2010, 1:e3.
73. Cornille K., Milea D., Amati-Bonneau P., Procaccio V., Zazoun L., Guillet V., El Achouri G., Delettre C., Gueguen N., Loiseau D., Muller A., Ferre M., Chevrollier A., Wallace D.C., Bonneau D., Hamel C., Reynier P., Lenaers G. Reversible optic neuropathy with OPA1 exon 5b mutation. Ann. Neurol. 2008, 63:667-671.
74. Corona P., Antozzi C., Carrara F., D'Incerti L., Lamantea E., Tiranti V., Zeviani M. A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients. Ann. Neurol. 2001, 49:106-110.
75. Cryns V., Yuan Y. Proteases to die for. Genes Dev. 1999, 12:1551-1570.
76. Danielson S.R., Wong A., Carelli V., Martinuzzi A., Schapira A.H., Cortopassi G.A. Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-induced apoptosis. J. Biol. Chem. 2002, 277:5810-5815.
77. Davies V.J., Hollins A.J., Piechota M.J., Yip W., Davies J.R., White K.E., Nicols P.P., Boulton M.E., Votruba M. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum. Mol. Genet. 2007, 16:1307-1318.
78. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
79. Delettre C., Lenaers G., Griffoin J.M., Gigarel N., Lorenzo C., Belenguer P., Pelloquin L., Grosgeorge J., Turc-Carel C., Perret E., Astarie-Dequeker C., Lasquellec L., Arnaud B., Ducommun B., Kaplan J., Hamel C.P. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 2000, 26:207-210.
80. Detmer S.A., Chan D.C. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J. Cell Biol. 2007, 176:405-414.
81. Diaz F., Moraes C.T. Mitochondrial biogenesis and turnover. Cell Calcium 2008, 44:24-35.
82. Distelmaier F., Koopman W.J., van den Heuvel L.P., Rodenburg R.J., Mayatepek E., Willems P.H., Smeitink J.A. Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 2009, 132:833-842.
83. Duchen M.R. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol. Aspects Med. 2004, 25:365-451.
84. Ehses S., Raschke I., Mancuso G., Bernacchia A., Geimer S., Tondera D., Martinou J.C., Westermann B., Rugarli E.I., Langer T. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J. Cell Biol. 2009, 187:1023-1036.
85. Elachouri G., Vidoni S., Zanna C., Pattyn A., Boukhaddaoui H., Gaget K., Yu-Wai-Man P., Gasparre G., Sarzi E., Delettre C., Olichon A., Loiseau D., Reynier P., Chinnery P.F., Rotig A., Carelli V., Hamel C.P., Rugolo M., Lenaers G. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res. 2011, 21:12-20.
86. Ellouze S., Augustin S., Bouaita A., Bonnet C., Simonutti M., Forster V., Picaud S., Sahel J.A., Corral-Debrinski M. Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am. J. Hum. Genet. 2008, 83:373-387.
87. Evans M.J., Scarpulla R.C. NRF-1: a trans-activator of nuclear encoded respiratory genes in animal cells. Genes Dev. 1990, 4:1023-1034.
88. Fortuna F., Barboni P., Liguori R., Valentino M.L., Savini G., Gellera C., Mariotti C., Rizzo G., Tonon C., Manners D., Lodi R., Sadun A.A., Carelli V. Visual system involvement in patients with Friedreich's ataxia. Brain 2009, 132:116-123.
89. Frezza C., Cipolat S., Martins de Brito O., Micaroni M., Beznoussenko G.V., Rudka T., Bartoli D., Polishuck R.S., Danial N.N., De Strooper B., Scorrano L. OPA1 controls apoptotic cristae remodelling independently from mitochondrial fusion. Cell 2006, 126:177-189.
90. Galkin A.S., Grivennikova V.G., Vinogradov A.V. →H+/2e- stoichiometry in NADH-quinone reductase reactions catalyzed by bovine heart submitochondrial particles. FEBS Lett. 1999, 451:157-161.
91. Galluzzi L., Kroemer G. Mitochondrial apoptosis without VDAC. Nat. Cell Biol. 2007, 9:487-489.
92. Gandre-Babbe S., van der Bliek A.M. The novel tail-anchored membrane protein Mff controls mitochondrial and peroxisomal fission in mammalian cells. Mol. Biol. Cell 2008, 19:2402-2412.
93. Geromel V., Darin N., Chrétien D., Bénit P., DeLonlay P., Rötig A., Munnich A., Rustin P. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol. Genet. Metab. 2002, 77:21-30.
94. Ghelli A., Zanna C., Porcelli A.M., Schapira A.H., Martinuzzi A., Carelli V., Rugolo M. Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J. Biol. Chem. 2003, 278:4145-4150.
95. Ghezzi D., Sevrioukova I., Invernizzi F., Lamperti C., Mora M., D'Adamo P., Novara F., Zuffardi O., Uziel G., Zeviani M. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am. J. Hum. Genet. 2010, 86:639-649.
96. Giordano C., Montopoli M., Perli E., Orlandi M., Fantin M., Ross-Cisneros F.N., Caparrotta L., Martinuzzi A., Ragazzi E., Ghelli A., Sadun A.A., d'Amati G., Carelli V. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 2011, 134:220-234.
97. Giorgio V., Petronilli V., Ghelli A., Carelli V., Rugolo M., Lenaz G., Bernardi P. The effects of idebenone on mitochondrial bioenergetics. Biochim. Biophys. Acta 2012, 1817:363-369.
98. Gómez-Durán A., Pacheu-Grau D., Martínez-Romero I., López-Gallardo E., López-Pérez M.J., Montoya J., Ruiz-Pesini E. Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy. Biochim. Biophys. Acta 2012, 1822:1216-1222.
99. Gray R.E., Law R.H., Devenish R.J., Nagley P. Allotopic expression of mitochondrial ATP synthase genes in nucleus of Saccharomyces cerevisiae. Methods Enzymol. 1996, 264:369-389.
100. Griparic L., van der Wel N.N., Orozco I.J., Peters P.J., van der Bliek A.M. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J. Biol. Chem. 2004, 279:18792-18798.
101. Griparic L., Kanazawa T., van der Bliek A.M. Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J. Cell Biol. 2007, 178:757-764.
102. Guo L., Duggan J., Cordeiro M.F. Alzheimer's disease and retinal neurodegeneration. Curr. Alzheimer Res. 2010, 7:3-14.
103. Guy J., Qi X., Pallotti F., Schon E.A., Manfredi G., Carelli V., Martinuzzi A., Hauswirth W.W., Lewin A.S. Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann. Neurol. 2002, 52:534-542.
104. Haefeli R.H., Erb M., Gemperli A.C., Robay D., Courdier Fruh I., Anklin C., Dallmann R., Gueven N. NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS One 2011, 6:e17963.
105. Hajee M.E., March W.F., Lazzaro D.R., Wolintz A.H., Shrier E.M., Glazman S., Bodis-Wollner I.G. Inner retinal layer thinning in Parkinson disease. Arch. Ophthalmol. 2009, 127:737-741.
106. Handy D.E., Loscalzo J. Redox regulation of mitochondrial function. Antioxid. Redox Signal. 2012, 16(11):1323-1367.
107. Hanein S., Perrault I., Roche O., Gerber S., Khadom N., Rio M., Boddaert N., Jean-Pierre M., Brahimi N., Serre V., Chretien D., Delphin N., Fares-Taie L., Lachheb S., Rotig A., Meire F., Munnich A., Dufier J.-L., Kaplan J., Rozet J.-M. TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy. Am. J. Hum. Genet. 2009, 84:493-498.
108. Harding A.E., Sweeney M.G., Miller D.H., Mumford C.J., Kellar-Wood H., Menard D., McDonald W.I., Compston D.A. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992, 115:979-989.
109. Head B., Griparic L., Amiri M., Gandre-Babbe S., van der Bliek A.M. Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells. J. Cell Biol. 2009, 187:959-966.
110. Hinton D.R., Sadun A.A., Blanks J.C., Miller C.A. Optic-nerve degeneration inAlzheimer's disease. N. Engl. J. Med. 1986, 315:485-487.
111. Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331:717-719.
112. Hudson G., Keers S., Yu-Wai-Man P., Griffiths P., Huoponen K., Savontaus M.L., Nikoskelainen E., Zeviani M., Carrara F., Horvath R., Karcagi V., Spruijt L., de Coo I.F., Smeets H.J., Chinnery P.F. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am. J. Hum. Genet. 2005, 77:1086-1091.
113. Hudson G., Amati-Bonneau P., Blakely E.L., Stewart J.D., He L., Schaefer A.M., Griffiths P.G., Ahlqvist K., Suomalainen A., Reynier P., McFarland R., Turnbull D.M., Chinnery P.F., Taylor R.W. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008, 131:329-337.
114. Inoue H., Tanizawa Y., Wasson J., Behn P., Kalidas K., Bernal-Mizrachi E., Mueckler M., Marshall H., Donis-Keller H., Crock P., Rogers D., Mikuni M., Kumashiro H., Higashi K., Sobue G., Oka Y., Permutt M.A. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 1998, 20:143-148.
115. Inzelberg R., Ramirez J.A., Nisipeanu P., Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004, 44:2793-2797.
116. Iseri P.K., Altinaş O., Tokay T., Yükse L.N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities inAlzheimer disease. J. Neuroophthalmol. 2006, 26:18-24.
117. Ishihara N., Fujita Y., Oka T., Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 2006, 25:2966-2977.
118. Iyer S., Bergquist K., Young K., Gnaiger E., Rao R.R., Bennett J.P. Mitochondrial gene therapy improves respiration, biogenesis and transcription in G11778A Leber's hereditary optic neuropathy and T8993G Leigh's syndrome cells. Hum. Gene Ther. 2012, 23:647-657.
119. Ji Y., Jia X., Li S., Xiao X., Guo X., Zhang Q. Evaluation of the X-linked modifier loci for Leber hereditary optic neuropathy with the G11778A mutation in Chinese. Mol. Vis. 2010, 16:416-424.
120. Jin H., May M., Tranebjaerg L., Kendall E., Fontan G., Jackson J., Subramony S.H., Arena F., Lubs H., Smith S., Stevenson R., Schwartz C., Vetrie D. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat. Genet. 1996, 14:177-180.
121. Jones R.D., Donaldson I.M., Timmings P.L. Impairment of high-contrast visual acuity in Parkinson's disease. Mov. Disord. 1992, 7:232-238.
122. Jourdain A., Martinou J.C. Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int. J. Biochem. Cell Biol. 2009, 41:1884-1889.
123. Jun A.S., Brown M.D., Wallace D.C. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:6206-6210.
124. Kanki T., Klionsky D.J. Mitochondrial abnormalities drive cell death in Wolfram syndrome 2. Cell Res. 2009, 19:922-923.
125. Kelly D.P., Scarpulla R.C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004, 18:357-368.
126. Kerrison J.B., Arnould V.J., Ferraz Sallum J.M., Vagefi M.R., Barmada M.M., Li Y., Zhu D., Maumenee I.H. Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3. Arch. Ophthalmol. 1999, 117:805-810.
127. Kesler A., Vakhapova V., Korczyn A.D., Naftaliev E., Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin. Neurol. Neurosurg. 2011, 113:523-526.
128. Kinnally K.W., Antonsson B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis 2007, 12:857-868.
129. Kjer P., Jensen O.A., Klinken L. Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol. (Copenh) 1983, 61:300-312.
130. Kleta R., Skovby F., Christensen E., Rosenberg T., Gahl W.A., Anikster Y. 3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings. Mol. Genet. Metab. 2002, 76:201-206.
131. Klopstock T., Yu-Wai-Man P., Dimitriadis K., Rouleau J., Heck S., Bailie M., Atawan A., Chattopadhyay S., Schubert M., Garip A., Kernt M., Petraki D., Rummey C., Leinonen M., Metz G., Griffiths P.G., Meier T., Chinnery P.F. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 2011, 134:2677-2686.
132. Koehler C.M., Leuenberger D., Merchant S., Renold A., Junne T., Schatz G. Human deafness dystonia syndrome is a mitochondrial disease. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2141-2146.
133. Koopman W.J., Nijtmans L.G., Dieteren C.E., Roestenberg P., Valsecchi F., Smeitink J.A., Willems P.H. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid. Redox Signal. 2010, 12:1431-1470.
134. La Morgia, C., Barboni, P., Rizzo, G., Carbonelli, M., Savini, G., Scaglione, C., Capellari, S., Bonazza, S., Giannoccaro, M.P., Calandra-Buonaura, G., Liguori, R., Cortelli, P., Martinelli, P., Baruzzi, A., Carelli, V., in press. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern. Eur. J. Neurol. (Mar 21).
135. Lam B.L., Feuer W.J., Abukhalil F., Porciatti V., Hauswirth W.W., Guy J. Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1. Arch. Ophthalmol. 2010, 128:1129-1135.
136. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim. Biophys. Acta 1998, 1366:53-67.
137. Lenaz G. Mitochondria and reactive oxygen species. Which role in physiology and pathology?. Adv. Exp. Med. Biol. 2012, 942:93-136.
138. Lin J., Puigserver P., Donovan J., Tarr P., Spiegelman B.M. Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 2002, 277:1645-1648.
139. Lin J., Tarr P.T., Yang R., Rhee J., Puigserver P., Newgard C.B., Spiegelman B.M. PGC-1beta in the regulation of hepatic glucose and energy metabolism. J. Biol. Chem. 2003, 278:30843-30848.
140. Ling C., Poulsen P., Carlsson E., Ridderstråle M., Almgren P., Wojtaszewski J., Beck-Nielsen H., Groop L., Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J. Clin. Invest. 2004, 114:1518-1526.
141. Liolitsa D., Rahman S., Benton S., Carr L.J., Hanna M.G. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?. Ann. Neurol. 2003, 53:128-132.
142. Lodi R., Taylor D.J., Tabrizi S.J., Kumar S., Sweeney M., Wood N.W., Styles P., Radda G.K., Schapira A.H. In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy. Ann. Neurol. 1997, 42:573-579.
143. Lodi R., Tonon C., Valentino M.L., Manners D., Testa C., Malucelli E., La Morgia C., Barboni P., Carbonelli M., Schimpf S., Wissinger B., Zeviani M., Baruzzi A., Liguori R., Barbiroli B., Carelli V. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations. Arch. Neurol. 2011, 68:67-73.
144. Loiseau D., Chevrollier A., Verny C., Guillet V., Gueguen N., Pou de Crescenzo M.A., Ferré M., Malinge M.C., Guichet A., Nicolas G., Amati-Bonneau P., Malthièry Y., Bonneau D., Reynier P. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann. Neurol. 2007, 61:315-323.
145. Lu Y., Li Z., Zhang X., Ming B., Jia J., Wang R., Ma D. Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci. Lett. 2010, 480:69-72.
146. Magrané J., Sahawneh M.A., Przedborski S., Estévez Á G., Manfredi G. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J. Neurosci. 2012, 32:229-242.
147. Maguire A.M., Simonelli F., Pierce E.A., Pugh E.N., Mingozzi F., Bennicelli J., Banfi S., Marshall K.A., Testa F., Surace E.M., Rossi S., Lyubarsky A., Arruda V.R., Konkle B., Stone E., Sun J., Jacobs J., Dell'Osso L., Hertle R., Ma J.X., Redmond T.M., Zhu X., Hauck B., Zelenaia O., Shindler K.S., Maguire M.G., Wright J.F., Volpe N.J., McDonnell J.W., Auricchio A., High K.A., Bennett J. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 2008, 358:2240-2248.
148. Malfatti E., Bugiani M., Invernizzi F., de Souza C.F., Farina L., Carrara F., Lamantea E., Antozzi C., Confalonieri P., Sanseverino M.T., Giugliani R., Uziel G., Zeviani M. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain 2007, 130:1894-1904.
149. Manfredi G., Fu J., Ojaimi J., Sadlock J.E., Kwong J.Q., Guy J., Schon E.A. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat. Genet. 2002, 30(4):394-399. (Apr).
150. Marella M., Seo B.B., Thomas B.B., Matsuno-Yagi A., Yagi T. Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model. PLoS One 2010, 5:e11472.
151. Marelli C., Amati-Bonneau P., Reynier P., Layet V., Layet A., Stevanin G., Brissaud E., Bonneau D., Durr A., Brice A. Heterozygous OPA1 mutations in Behr syndrome. Brain 2011, 134:e169.
152. Martinou J.C., Youle R.J. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell 2011, 21:92-101.
153. Mashima Y., Hiida Y., Oguchi Y. Remission of Leber's hereditary optic neuropathy with idebenone. Lancet 1992, 340:368-369.
154. Mashima Y., Kigasawa K., Wakakura M., Oguchi Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?. J. Neuroophthalmol. 2000, 20:166-170.
155. Meier P., Finch A., Evan G. Apoptosis in development. Nature 2000, 407:796-801.
156. Melov S., Coskun P., Patel M., Tuinstra R., Cottrell B., Jun A.S., Zastawny T.H., Dizdaroglu M., Goodman S.I., Huang T.T., Miziorko H., Epstein C.J., Wallace D.C. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:846-851.
157. Milone M., Younge B.R., Wang J., Zhang S., Wong L.J. Mitochondrial disorder with OPA1 mutation lacking optic atrophy. Mitochondrion 2009, 9:279-281.
158. Milone M., Wang J., Liewluck T., Chen L.C., Leavitt J.A., Wong L.J. Novel POLG splice site mutation and optic atrophy. Arch. Neurol. 2011, 68:806-811.
159. MITOMAP A human mitochondrial genome database http://www.mitomap.org.
160. Mochel F., Haller R.G. Energy deficit in Huntington disease: why it matters. J. Clin. Invest. 2011, 121:493-499.
161. Moreno-Loshuertos R., Ferrín G., Acín-Pérez R., Gallardo M.E., Viscomi C., Pérez-Martos A., Zeviani M., Fernández-Silva P., Enríquez J.A. Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutations. PLoS Genet. 2011, 7:e1001379.
162. Moschos M.M., Tagaris G., Markopoulos I., Margetis I., Tsapakis S., Kanakis M., Koutsandrea C. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur. J. Ophthalmol. 2011, 21:24-29.
163. Mozdy A.D., McCaffery J.M., Shaw J.M. Dnm1p GTPase-mediated mitochondrial fission is a multi-step process requiring the novel integral membrane component Fis1p. J. Cell Biol. 2000, 151:367-380.
164. Nakada K., Hayashi J. Transmitochondrial mice as models for mitochondrial DNA based diseases. Exp. Anim. 2011, 60:421-431.
165. Newman N.J. Treatment of Leber hereditary optic neuropathy. Brain 2011, 134:2447-2450.
166. Nishioka T., Soemantri A., Ishida T. mtDNA/nDNA ratio in 14484 LHON mitochondrial mutation carriers. J. Hum. Genet. 2004, 49:701-705.
167. Novotny E.J., Singh G., Wallace D.C., Dorfman L.J., Louis A., Sogg R.L., Steinman L. Leber's disease and dystonia: a mitochondrial disease. Neurology 1986, 36:1053-1060.
168. Oca-Cossio J., Kenyon L., Hao H., Moraes C.T. Limitations of allotopic expression of mitochondrial genes in mammalian cells. Genetics 2003, 165:707-720.
169. Olichon A., Emorine L.J., Descoins E., Pelloquin L., Brichese L., Gas N., Guillou E., Delettre C., Valette A., Hamel C.P., Ducommun B., Lenaers G., Belenguer P. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett. 2002, 523:171-176.
170. Olichon A., Baricault L., Gas N., Guillou E., Valette A., Belenguer P., Lenaers G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 2003, 278:7743-7746.
171. Olichon A., Elachouri G., Baricault L., Delettre C., Belenguer P., Lenaers G. OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis. Cell Death Differ. 2007, 14:682-692.
172. Olichon A., Landes T., Arnauné-Pelloquin L., Emorine L.J., Mils V., Guichet A., Delettre C., Hamel C., Amati-Bonneau P., Bonneau D., Reynier P., Lenaers G., Belenguer P. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J. Cell. Physiol. 2007, 211:423-430.
173. Otera H., Wang C., Cleland M.M., Setoguchi K., Yokota S., Youle R.J., Mihara K. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 2010, 191:1141-1158.
174. Palmer C.S., Osellame L.D., Stojanovski D., Ryan M.T. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell. Signal. 2011, 23:1534-1545.
175. Paquet C., Boissonnot M., Roger F., Dighiero P., Gil R., Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci. Lett. 2007, 420(2):97-99. (Jun 13).
176. Paradies G., Petrosillo G., Paradies V., Ruggiero F.M. Oxidative stress, mitochondrial bioenergetics, and cardiolipin in aging. Free Radic. Biol. Med. 2010, 48:1286-1295.
177. Parisi V., Restuccia R., Fattapposta F., Mina C., Bucci M.G., Pierelli F. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin. Neurophysiol. 2001, 112:1860-1867.
178. Perales-Clemente E., Fernández-Silva P., Acín-Pérez R., Pérez-Martos A., Enríquez J.A. Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task?. Nucleic Acids Res. 2011, 39:225-234.
179. Perier C., Tieu K., Guégan C., Caspersen C., Jackson-Lewis V., Carelli V., Martinuzzi A., Hirano M., Przedborski S., Vila M. Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19126-19131.
180. Pretegiani E., Rufa A., Gallus G.N., Cardaioli E., Malandrini A., Federico A. Spastic paraplegia in 'dominant optic atrophy plus' phenotype due to OPA1 mutation. Brain 2011, 134:e195.
181. Pulkes T., Eunson L., Patterson V., Siddiqui A., Wood N.W., Nelson I.P., Morgan-Hughes J.A., Hanna M.G. The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS. Ann. Neurol. 1999, 46:916-919.
182. Qi X., Lewin A.S., Hauswirth W.W., Guy J. Suppression of complex I gene expression induces optic neuropathy. Ann. Neurol. 2003, 53:198-205.
183. Ramos Cdo.V., Bellusci C., Savini G., Carbonelli M., Berezovsky A., Tamaki C., Cinoto R., Sacai P.Y., Moraes-Filho M.N., Miura H.M., Valentino M.L., Iommarini L., De Negri A.M., Sadun F., Cortelli P., Montagna P., Salomao S.R., Sadun A.A., Carelli V., Barboni P. Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy. Invest. Ophthalmol. Vis. Sci. 2009, 50:1666-1674.
184. Reddy P.H., Tripathi R., Troung Q., Tirumala K., Reddy T.P., Anekonda V., Shirendeb U.P., Calkins M.J., Reddy A.P., Mao P., Manczak M. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim. Biophys. Acta 2012, 1822:639-649.
185. Reed T.T. Lipid peroxidation and neurodegenerative disease. Free Radic. Biol. Med. 2011, 51:1302-1319.
186. Rendtorff N.D., Lodahl M., Boulahbel H., Johansen I.R., Pandya A., Welch K.O., Norris V.W., Arnos K.S., Bitner-Glindzicz M., Emery S.B., Mets M.B., Fagerheim T., Eriksson K., Hansen L., Bruhn H., Möller C., Lindholm S., Ensgaard S., Lesperance M.M., Tranebjaerg L. Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. Am. J. Med. Genet. A 2011, 155A:1298-1313.
187. Reynier P., Amati-Bonneau P., Verny C., Olichon A., Simard G., Guichet A., Bonnemains C., Malecaze F., Malinge M.C., Pelletier J.B., Calvas P., Dollfus H., Belenguer P., Malthièry Y., Lenaers G., Bonneau D. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J. Med. Genet. 2004, 41:e110.
188. Rojo M., Legros F., Chateau D., Lombès A. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 2002, 115:1663-1674.
189. Rötig A., Cormier V., Chatelain P., Francois R., Saudubray J.M., Rustin P., Munnich A. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MI 222300). J. Clin. Invest. 1993, 91:1095-1098.
190. Rötig A., de Lonlay P., Chretien D., Foury F., Koenig M., Sidi D., Munnich A., Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat. Genet. 1997, 17:215-217.
191. Rouzier C., Bannwarth S., Chaussenot A., Chevrollier A., Verschueren A., Bonello-Palot N., Fragaki K., Cano A., Pouget J., Pellissier J.F., Procaccio V., Chabrol B., Paquis-Flucklinger V. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype. Brain 2012, 135:23-34.
192. Ryu S.W., Jeong H.J., Choi M., Karbowski M., Choi C. Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation. Cell. Mol. Life Sci. 2010, 67:2839-2850.
193. Sabet-Peyman E.J., Khaderi K.R., Sadun A.A. Is leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case. J. Neuroophthalmol. 2012, 32:54-57.
194. Sadun A.A., Bassi C.J. Optic nerve damage in Alzheimer's disease. Ophthalmology 1990, 97:9-17.
195. Sadun A.A., Borchert M., DeVita E., Hinton D.R., Bassi C.J. Assessment of visual impairment in patients with Alzheimer's disease. Am. J. Ophthalmol. 1987, 104:113-120.
196. Sadun A.A., Win P.H., Ross-Cisneros F.N., Walker S.O., Carelli V. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans. Am. Ophthalmol. Soc. 2000, 98:223-232. (discussion 232-5).
197. Sadun A.A., La Morgia C., Carelli V. Leber's hereditary optic neuropathy. Curr. Treat. Options. Neurol. 2011, 13:109-117.
198. Sadun A.A., Chicani C.F., Ross-Cisneros F.N., Barboni P., Thoolen M., Shrader W.D., Kubis K., Carelli V., Miller G. Effect of EPI-743 on the clinical course of the mitochondrial disease leber hereditary optic neuropathy. Arch. Neurol. 2012, 69:331-338.
199. Santel A., Fuller M.T. Control of mitochondrial morphology by a human mitofusin. J. Cell Sci. 2001, 114:867-874.
200. Sartucci F., Borghetti D., Bocci T., Murri L., Orsini P., Porciatti V., Origlia N., Domenici L. Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials. Brain Res. Bull. 2010, 82:169-176.
201. Satoh M., Hamamoto T., Seo N., Kagawa Y., Endo H. Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria. Biochem. Biophys. Res. Commun. 2003, 300:482-493.
202. Savini G., Barboni P., Valentino M.L., Montagna P., Cortelli P., De Negri A.M., Sadun F., Bianchi S., Longanesi L., Zanini M., Carelli V. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology 2005, 112:127-131.
203. Saxton W.M., Hollenbeck P.J. The axonal transport of mitochondria. J. Cell Sci. 2012, 125:2095-2104.
204. Scarpulla R.C. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 2002, 286:81-89.
205. Scarpulla R.C. Nuclear control of respiratory gene expression in mammalian cells. J. Cell. Biochem. 2006, 97:673-683.
206. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88:611-638.
207. Scarpulla R.C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 2011, 1813:1269-1278.
208. Schaaf C.P., Blazo M., Lewis R.A., Tonini R.E., Takei H., Wang J., Wong L.J., Scaglia F. Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations. Mol. Genet. Metab. 2011, 103:383-387.
209. Schapira A.H. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 2008, 7:97-109.
210. Schon E.A., Area-Gomez E. Is Alzheimer's disease a disorder of mitochondria-associated membranes?. J. Alzheimers Dis. 2010, 20(Suppl. 2):S281-S292.
211. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 2003, 278:9013-9018.
212. Shankar S.P., Fingert J.H., Carelli V., Valentino M.L., King T.M., Daiger S.P., Salomao S.R., Berezovsky A., Belfort R., Braun T.A., Sheffield V.C., Sadun A.A., Stone E.M. Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet. 2008, 29:17-24.
213. Shirendeb U., Reddy A.P., Manczak M., Calkins M.J., Mao P., Tagle D.A., Reddy P.H. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum. Mol. Genet. 2011, 20:1438-1455.
214. Shrader W.D., Amagata A., Barnes A., Enns G.M., Hinman A., Jankowski O., Kheifets V., Komatsuzaki R., Lee E., Mollard P., Murase K., Sadun A.A., Thoolen M., Wesson K., Miller G. α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging. Bioorg. Med. Chem. Lett. 2011, 21:3693-3698.
215. Silva M.F., Faria P., Regateiro F.S., Forjaz V., Januário C., Freire A., Castelo-Branco M. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease. Brain 2005, 128:2260-2271.
216. Skulachev V.P. Mitochondrial filaments and clusters as intracellular power transmitting cables. Trends Biochem. Sci. 2001, 26:23-29.
217. Smeitink J., van den Heuvel L., DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2001, 2:342-352.
218. Smirnova E., Shurland D.L., Ryazantsev S.N., van der Bliek A.M. A human dynamin-related protein controls the distribution of mitochondria. J. Cell Biol. 1998, 143:351-358.
219. Smirnova E., Griparic L., Shurland D.L., van der Bliek A.M. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 2001, 12:2245-2256.
220. Song Z., Chen H., Fiket M., Alexander C., Chan D.C. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J. Cell Biol. 2007, 178:749-755.
221. Spinazzi M., Cazzola S., Bortolozzi M., Baracca A., Loro E., Casarin A., Solaini G., Sgarbi G., Casalena G., Cenacchi G., Malena A., Frezza C., Carrara F., Angelini C., Scorrano L., Salviati L., Vergani L. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. Hum. Mol. Genet. 2008, 17:3291-3302.
222. Spruijt L., Smeets H.J., Hendrickx A., Bettink-Remeijer M.W., Maat-Kievit A., Schoonderwoerd K.C., Sluiter W., de Coo I.F., Hintzen R.Q. A MELAS-associated ND1 mutation causing leber hereditary optic neuropathy and spastic dystonia. Arch. Neurol. 2007, 64:890-893.
223. Stemmler T.L., Lesuisse E., Pain D., Dancis A. Frataxin and mitochondrial FeS cluster biogenesis. J. Biol. Chem. 2010, 285:26737-26743.
224. Stricker S., Oberwahrenbrock T., Zimmermann H., Schroeter J., Endres M., Brandt A.U., Paul F. Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS One 2011, 6:e23024.
225. Strom T.M., Hortnagel K., Hofmann S., Gekeler F., Scharfe C., Rabl W., Gerbitz K.D., Meitinger T. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet. 1998, 7:2021-2028.
226. Szabadkai G., Simoni A.M., Bianchi K., De Stefani D., Leo S., Wieckowski M.R., Rizzuto R. Mitochondrial dynamics and Ca2+ signaling. Biochim. Biophys. Acta 2006, 1763:442-449.
227. Tang S., Le P.K., Tse S., Wallace D.C., Huang T. Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production. PLoS One 2009, 4:e4492.
228. Taylor R.W., Birch-Machin M.A., Schaefer J., Taylor L., Shakir R., Ackrell B.A., Cochran B., Bindoff L.A., Jackson M.J., Griffiths P., Turnbull D.M. Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia. Ann. Neurol. 1996, 39:224-232.
229. Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9:231-241.
230. Thornberry N., Lazebnik Y. Caspases: enemies within. Science 1998, 281:1312-1316.
231. Tondera D., Santel A., Schwarzer R., Dames S., Giese K., Klippel A., Kaufmann J. Knockdown of MTP18, a novel phosphatidylinositol 3-kinase-dependent protein, affects mitochondrial morphology and induces apoptosis. J. Biol. Chem. 2004, 279:31544-31555.
232. Tondera D., Czauderna F., Paulick K., Schwarzer R., Kaufmann J., Santel A. The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J. Cell Sci. 2005, 118:3049-3059.
233. Tranebjaerg L., Jensen P.K., Van Ghelue M., Vnencak-Jones C.L., Sund S., Elgjo K., Jakobsen J., Lindal S., Warburg M., Fuglsang-Frederiksen A., Skullerud K. Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene. Ophthalmic Genet. 2001, 22:207-223.
234. Valentino M.L., Barboni P., Ghelli A., Bucchi L., Rengo C., Achilli A., Torroni A., Lugaresi A., Lodi R., Barbiroli B., Dotti M., Federico A., Baruzzi A., Carelli V. The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. Ann. Neurol. 2004, 56:631-641.
235. Valentino M.L., Barboni P., Rengo C., Achilli A., Torroni A., Lodi R., Tonon C., Barbiroli B., Fortuna F., Montagna P., Baruzzi A., Carelli V. The 13042G>A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype. J. Med. Genet. 2006, 43:e38.
236. Van Bergen N.J., Trounce I.A., Mackey D.A., Hewitt A.V., Kong G., Crowston J.G. Decreased mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy. Abstract Presentation 4131/A387 2009.
237. Vaux D.L., Korsmeyer S.J. Cell death in development. Cell 1999, 96:245-254.
238. Verny C., Amati-Bonneau P., Dubas F., Malthiéry Y., Reynier P., Bonneau D. An OPA3 gene mutation is responsible for the disease associating optic atrophy and cataract with extrapyramidal signs. Rev. Neurol. 2005, 161:451-454.
239. Verny C., Loiseau D., Scherer C., Lejeune P., Chevrollier A., Gueguen N., Guillet V., Dubas F., Reynier P., Amati-Bonneau P., Bonneau D. Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology 2008, 70:1152-1153.
240. Viscomi C., Bottani E., Civiletto G., Cerutti R., Moggio M., Fagiolari G., Schon E.A., Lamperti C., Zeviani M. In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis. Cell Metab. 2011, 14:80-90.
241. Vives-Bauza C., Przedborski S. Mitophagy: the latest problem for Parkinson's disease. Trends Mol. Med. 2011, 17:158-165.
242. Vora A.J., Lilleyman J.S. Wolfram syndrome: mitochondrial disorder. Lancet 1993, 342:1059.
243. Wallace D.C. A new manifestation of Leber's disease and a new explanation for the agency responsible for its unusual pattern of inheritance. Brain 1970, 93:121-132.
244. Wallace D.C. Mouse models for mitochondrial disease. Am. J. Med. Genet. 2001, 106:71-93.
245. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas L.J., Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430.
246. Wang C., Youle R.J. The role of mitochondria in apoptosis. Annu. Rev. Genet. 2009, 43:95-118.
247. Wang K., Takahashi Y., Gao Z.L., Wang G.X., Chen X.W., Goto J., Lou J.N., Tsuji S. Mitochondrial ND3 as the novel causative gene for Leber hereditary optic neuropathy and dystonia. Neurogenetics 2009, 10:337-345.
248. Waterham H.R., Koster J., van Roermund C.W., Mooyer P.A., Wanders R.J., Leonard J.V. A lethal defect of mitochondrial and peroxisomal fission. N. Engl. J. Med. 2007, 356:1736-1741.
249. Wenz T., Diaz F., Spiegelman B.M., Moraes C.T. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 2008, 8:249-256.
250. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 2010, 11:872-884.
251. Williams P.A., Morgan J.E., Votruba M. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain 2010, 133:2942-2951.
252. Williams P.A., Morgan J.E., Votruba M. Mouse models of dominant optic atrophy: what do they tell us about the pathophysiology of visual loss?. Vision Res. 2011, 51:229-234.
253. Williams P.A., Piechota M., von Ruhland C., Taylor E., Morgan J.E., Votruba M. Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity. Brain 2012, 135:493-505.
254. Winkelmann J., Lin L., Schormair B., Kornum B.R., Faraco J., Plazzi G., Melberg A., Cornelio F., Urban A.E., Pizza F., Poli F., Grubert F., Wieland T., Graf E., Hallmayer J., Strom T.M., Mignot E. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum. Mol. Genet. 2012, 21:2205-2210.
255. Wong A., Cavelier L., Collins-Schramm H.E., Seldin M.F., McGrogan M., Savontaus M.L., Cortopassi G.A. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum. Mol. Genet. 2002, 11:431-438.
256. Yarosh W., Monserrate J., Tong J.J., Tse S., Le P.K., Nguyen K., Brachmann C.B., Wallace D.C., Huang T. The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment. PLoS Genet. 2008, 4:e6.
257. Yavas G.F., Yilmaz O., Küsbeci T., Oztürk F. The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. Eur. J. Ophthalmol. 2007, 17:812-816.
258. Yen M.Y., Lee H.C., Liu J.H., Wei Y.H. Compensatory elevation of complex II activity in Leber's hereditary optic neuropathy. Br. J. Ophthalmol. 1996, 80:78-81.
259. Yen M.Y., Chen C.S., Wang A.G., Wei Y.H. Increase of mitochondrial DNA in blood cells of patients with Leber's hereditary optic neuropathy with 11778 mutation. Br. J. Ophthalmol. 2002, 86:1027-1030.
260. Yu-Wai-Man P., Griffiths P.G., Gorman G.S., Lourenco C.M., Wright A.F., Auer-Grumbach M., Toscano A., Musumeci O., Valentino M.L., Caporali L., Lamperti C., Tallaksen C.M., Duffey P., Miller J., Whittaker R.G., Baker M.R., Jackson M.J., Clarke M.P., Dhillon B., Czermin B., Stewart J.D., Hudson G., Reynier P., Bonneau D., Marques W., Lenaers G., McFarland R., Taylor R.W., Turnbull D.M., Votruba M., Zeviani M., Carelli V., Bindoff L.A., Horvath R., Amati-Bonneau P., Chinnery P.F. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010, 133:771-786.
261. Yu-Wai-Man P., Griffiths P.G., Chinnery P.F. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog. Retin. Eye Res. 2011, 30:81-114.
262. Zanna C., Ghelli A., Porcelli A.M., Martinuzzi A., Carelli V., Rugolo M. Caspase-independent death of Leber's hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and Endonuclease G. Apoptosis 2005, 10:997-1007.
263. Zanna C., Ghelli A., Porcelli A.M., Karbowski M., Youle R.J., Schimpf S., Wissinger B., Pinti M., Cossarizza A., Vidoni S., Valentino M.L., Rugolo M., Carelli V. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008, 131:352-367.
264. Zhang Y., Chan D.C. Structural basis for recruitment of mitochondrial fission complexes by Fis1. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18526-18530.
265. Zhang P., Hinshaw J.E. Three-dimensional reconstruction of dynamin in the constricted state. Nat. Cell Biol. 2001, 3:922-926.
266. Zhang Y., Marcillat O., Giulivi C., Ernster L., Davies K.J. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 1990, 265:16330-16336.
267. Zhang X., Jones D., Gonzalez-Lima F. Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction. Neurosci. Lett. 2002, 326:97-100.
268. Zhang A.M., Jia X., Guo X., Zhang Q., Yao Y.G. Mitochondrial DNA mutation m.10680G>A is associated with Leber hereditary optic neuropathy in Chinese patients. J. Transl. Med. 2012, 10:43.
269. Zhao F., Guan M., Zhou X., Yuan M., Liang M., Liu Q., Liu Y., Zhang Y., Yang L., Tong Y., Wei Q.P., Sun Y.H., Qu J., Guan M.X. Leber's hereditary optic neuropathy is associated with mitochondrial ND6 T14502C mutation. Biochem. Biophys. Res. Commun. 2009, 389:466-472.
270. Zorzano A., Hernández-Alvarez M.I., Palacín M., Mingrone G. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes. Biochim. Biophys. Acta 2010, 1797:1028-1033.
271. Zuchner S., Mersiyanova I.V., Muglia M., Bissar-Tadmouri N., Rochelle J., Dadali E.L., Zappia M., Nelis E., Patitucci A., Senderek J., Parman Y., Evgrafov O., Jonghe P.D., Takahashi Y., Tsuji S., Pericak-Vance M.A., Quattrone A., Battaloglu E., Polyakov A.V., Timmerman V., Schroder J.M., Vance J.M. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 2004, 36:449-451.
272. Zuchner S., De Jonghe P., Jordanova A., Claeys K.G., Guergueltcheva V., Cherninkova S., Hamilton S.R., Van Stavern G., Krajewski K.M., Stajich J., Tournev I., Verhoeven K., Langerhorst C.T., de Visser M., Baas F., Bird T., Timmerman V., Shy M., Vance J.M. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann. Neurol. 2006, 59:276-281.